BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29939957)

  • 1. Detection of Metastatic Meningioma to the Liver Using 68Ga-DOTA-Octreotate PET/CT.
    Villanueva-Meyer JE; Magill ST; Lee JC; Umetsu SE; Flavell RR
    Clin Nucl Med; 2018 Sep; 43(9):e338-e340. PubMed ID: 29939957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-Body Staging of Metastatic Atypical Meningioma Using 68Ga-DOTATATE PET/CT.
    Unterrainer M; Ilhan H; Vettermann F; Cyran CC; Tonn JC; Niyazi M; Bartenstein P; Albert NL
    Clin Nucl Med; 2019 Mar; 44(3):227-228. PubMed ID: 30589668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of incidental brain uptake on 68Ga-DOTATATE PET-CT in neuroendocrine tumour patients.
    Cleary JO; Yeung J; McMeekin H; Wilhelm T; Wagner T
    Nucl Med Commun; 2016 Nov; 37(11):1197-205. PubMed ID: 27399848
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Kowalski ES; Khairnar R; Gryaznov AA; Kesari V; Koroulakis A; Raghavan P; Chen W; Woodworth G; Mishra M
    Radiat Oncol; 2021 Aug; 16(1):151. PubMed ID: 34399805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating dural metastases from meningioma: role of 68Ga DOTA-NOC PET/CT.
    Purandare NC; Puranik A; Shah S; Agrawal A; Gupta T; Moiyadi A; Shetty P; Shridhar E; Patil V; Rangarajan V
    Nucl Med Commun; 2020 Apr; 41(4):356-362. PubMed ID: 31939900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Detection of Transosseous Meningiomas Using
    Kunz WG; Jungblut LM; Kazmierczak PM; Vettermann FJ; Bollenbacher A; Tonn JC; Schichor C; Rominger A; Albert NL; Bartenstein P; Reiser MF; Cyran CC
    J Nucl Med; 2017 Oct; 58(10):1580-1587. PubMed ID: 28450556
    [No Abstract]   [Full Text] [Related]  

  • 7. 68Ga-DOTATOC PET/CT Differentiates Meningioma From Dural Metastases.
    Unterrainer M; Ruf V; Ilhan H; Vettermann FJ; Cyran CC; Niyazi M; Bartenstein P; Tonn JC; Albert NL
    Clin Nucl Med; 2019 May; 44(5):412-413. PubMed ID: 30829858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Brain Incidental Lesions Detected by
    Albano D; Treglia G; Dondi F; Bertagna F
    Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888635
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue.
    Rachinger W; Stoecklein VM; Terpolilli NA; Haug AR; Ertl L; Pöschl J; Schüller U; Schichor C; Thon N; Tonn JC
    J Nucl Med; 2015 Mar; 56(3):347-53. PubMed ID: 25635133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 68Ga DOTATATE PET/CT of Synchronous Meningioma and Prolactinoma.
    Basu S; Ranade R; Hazarika S
    Clin Nucl Med; 2016 Mar; 41(3):230-1. PubMed ID: 26462040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidural Metastases From Follicular Thyroid Cancer Mimicking Meningiomas in 68Ga-DOTATATE PET.
    Unterrainer M; Ilhan H; Todica A; Bartenstein P; Albert NL
    Clin Nucl Med; 2017 Oct; 42(10):805-806. PubMed ID: 28806249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallium-68 DOTATATE PET in the Evaluation of Intracranial Meningiomas.
    Ivanidze J; Roytman M; Lin E; Magge RS; Pisapia DJ; Liechty B; Karakatsanis N; Ramakrishna R; Knisely J; Schwartz TH; Osborne JR; Pannullo SC
    J Neuroimaging; 2019 Sep; 29(5):650-656. PubMed ID: 31107591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary Molecular and Metabolic Characterization of Meningiomas With DOTATATE and FDG-PET: Advancing Treatment Planning and Prognostication.
    Dressen MS; Muthukrishnan A; Tragon TR; Lieberman FS; Mountz JM
    Clin Nucl Med; 2019 Jan; 44(1):e26-e27. PubMed ID: 30371576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung Metastases of Intracranial Atypical Meningioma Diagnosed on Posttherapeutic Imaging After 177Lu-DOTATATE Therapy.
    Backhaus P; Huss S; Kösek V; Weckesser M; Rahbar K
    Clin Nucl Med; 2018 Jun; 43(6):e184-e185. PubMed ID: 29688946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Prospective Registry Study of
    Perlow HK; Nalin AP; Handley D; Gokun Y; Blakaj DM; Beyer SJ; Thomas EM; Raval RR; Boulter D; Kleefisch C; Bovi J; Chen WC; Braunstein SE; Raleigh DR; Knisely JPS; Ivanidze J; Palmer JD
    Int J Radiat Oncol Biol Phys; 2024 Mar; 118(4):979-985. PubMed ID: 37871886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin receptor-positive granulomatous inflammation mimicking as meningioma on simultaneous PET/MRI.
    Taneja S; Jena A; Kaul S; Jha A; Sogani SK
    Clin Nucl Med; 2015 Jan; 40(1):e71-2. PubMed ID: 24662657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-Specific Membrane Antigen-Avid Meningioma Detected in 68Ga-Prostate-Specific Membrane Antigen PET/CT.
    Gupta N; Verma R; Belho ES
    Clin Nucl Med; 2020 Sep; 45(9):692-693. PubMed ID: 32604120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 'double pituitary hot spot' sign of skull base meningioma on gallium-68-labelled somatostatin analogue PET.
    Law WP; Fiumara F; Fong W; Macfarlane DJ
    J Med Imaging Radiat Oncol; 2013 Dec; 57(6):680-3. PubMed ID: 24283556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifocal Meningiomas Mimicking Dural-Based Intracranial Metastases at 18F-Fluciclovine PET/CT.
    Manganaro MS; Millet JD; Manganaro MS
    Clin Nucl Med; 2019 Jul; 44(7):594-595. PubMed ID: 31107759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 68Ga-DOTA-peptide PET/CT for radiotherapy planning and evaluating treatment response in the management of meningiomas.
    Usmani S; Jain A; Hashmi SF; Mula-Hussain L; Riyami KA; Abubakar S; Shamim MS
    J Pak Med Assoc; 2023 Jun; 73(6):1340-1343. PubMed ID: 37427649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.